Adherence to treatment is a complex and multifaceted issue that can substantially alter the outcome of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

Leuk Res. 2012 Jul;36(7):804-5. doi: 10.1016/j.leukres.2012.02.032. Epub 2012 Mar 27.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Assessment of Medication Adherence*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Protein Kinase Inhibitors / administration & dosage*

Substances

  • Protein Kinase Inhibitors